2024-04-08 13:25:24 ET
ABIVAX Société Anonyme (AAVXF)
Q4 2023 Earnings Conference Call
April 08, 2024, 08:30 AM ET
Company Participants
Patrick Malloy - SVP, IR
Marc de Garidel - CEO
Sheldon Sloan - Chief Medical Officer
Didier Scherrer - Chief Scientific Officer
Conference Call Participants
Thomas Smith - Leerink Partners
Vikram Purohit - Morgan Stanley
Julian Harrison - BTIG
Presentation
Operator
Ladies and gentlemen, thank you for standing by. Welcome to ABIVAX Conference Call to discuss 2023 Financial Results and Business Update. My name is Sandra, and I'll be your operator for today's call. [Operator Instructions] As a reminder, this call is being recorded at ABIVAX's request.
Now I would like to introduce your host for today's call, Patrick Malloy, Senior Vice President, Investor Relations.
Pat, please go ahead.
Patrick Malloy
Thank you, operator. And good morning and good afternoon to everyone. Welcome to today's call, during which we'll provide an update on our financial results for the full year ended December 31, 2023, as well as key program updates across business. On April 2nd, we issued a press release summarizing our financial results. And on April 5th, we filed our 20-F and Universal Registration Document, all of which can be found on the ABIVAX's website....
Read the full article on Seeking Alpha
For further details see:
ABIVAX Société Anonyme (AAVXF) Q4 2023 Earnings Call Transcript